CAH - Cardinal Health, Inc.
NYSE
->
Healthcare
->
Medical Distribution
Dublin,
United States
Type: Equity
CAH price evolution
CAH
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5133 | $3718 | ||
| Short term investments | ||||
| Net receivables | $11781 | $12084 | $11566 | |
| Inventory | $15619 | $14957 | $17277 | |
| Total current assets | $32905 | $34884 | $35734 | |
| Long term investments | ||||
| Property, plant & equipment | $2535 | $2529 | $2470 | |
| Goodwill & intangible assets | $6450 | $6507 | ||
| Total noncurrent assets | $10237 | $10146 | ||
| Total investments | ||||
| Total assets | $43059 | $45121 | $45880 | |
| Current liabilities | ||||
| Accounts payable | $30365 | $31759 | $32089 | |
| Deferred revenue | ||||
| Short long term debt | $434 | $1187 | ||
| Total current liabilities | $34678 | $35640 | $36306 | |
| Long term debt | $4224 | $4658 | $4667 | |
| Total noncurrent liabilities | $12693 | $12836 | ||
| Total debt | $5092 | $5854 | ||
| Total liabilities | $46336 | $48333 | $49142 | |
| Shareholders' equity | ||||
| Retained earnings | $14 | -$286 | -$289 | |
| Other shareholder equity | -$155 | -$167 | -$160 | |
| Total shareholder equity | -$3213 | -$3265 | ||
| (in millions $) | 31 Jan 2025 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5133 | $4043 | $4717 | $3407 |
| Short term investments | ||||
| Net receivables | $12084 | $11344 | $10561 | $9103 |
| Inventory | $14957 | $15940 | $15636 | $14594 |
| Total current assets | $34884 | $33833 | $32935 | $31048 |
| Long term investments | ||||
| Property, plant & equipment | $2529 | $2462 | $2361 | $2360 |
| Goodwill & intangible assets | $6450 | $6081 | $7629 | $10094 |
| Total noncurrent assets | $10237 | $9584 | $10943 | $13405 |
| Total investments | ||||
| Total assets | $45121 | $43417 | $43878 | $44453 |
| Current liabilities | ||||
| Accounts payable | $31759 | $29813 | $27128 | $23700 |
| Deferred revenue | ||||
| Short long term debt | $434 | $792 | $580 | $871 |
| Total current liabilities | $35640 | $33706 | $30550 | $27624 |
| Long term debt | $4658 | $3909 | $4735 | $5365 |
| Total noncurrent liabilities | $12693 | $12562 | $14034 | $15035 |
| Total debt | $5092 | $4701 | $5315 | $6236 |
| Total liabilities | $48333 | $46268 | $44584 | $42659 |
| Shareholders' equity | ||||
| Retained earnings | -$286 | -$534 | -$280 | $1205 |
| Other shareholder equity | -$167 | -$151 | -$114 | -$34 |
| Total shareholder equity | -$3213 | -$2852 | -$709 | $1791 |
| (in millions $) | 1 May 2025 | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $52277 | $59708 | $54911 | |
| Cost of revenue | $57855 | $52964 | ||
| Gross Profit | $1902 | $1853 | $1947 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1238 | $1282 | ||
| Total operating expenses | $1345 | $1461 | $1573 | |
| Operating income | $392 | $374 | ||
| Income from continuing operations | ||||
| EBIT | $394 | $373 | ||
| Income tax expense | $124 | $162 | $82 | |
| Interest expense | -$32 | -$4 | $33 | |
| Net income | ||||
| Net income | $416 | $236 | $258 | |
| Income (for common shares) | $236 | $258 | ||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $226827 | $205012 | $181364 | $162467 |
| Cost of revenue | $219413 | $198123 | $174819 | $155689 |
| Gross Profit | $7414 | $6889 | $6545 | $6778 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $5000 | $4834 | $4557 | $4533 |
| Total operating expenses | $6162 | $6158 | $7157 | $6259 |
| Operating income | $1252 | $731 | -$612 | $519 |
| Income from continuing operations | ||||
| EBIT | $1251 | $730 | -$621 | $502 |
| Income tax expense | $348 | $376 | $163 | -$289 |
| Interest expense | $51 | $93 | $149 | $180 |
| Net income | ||||
| Net income | $852 | $261 | -$933 | $611 |
| Income (for common shares) | $852 | $261 | -$933 | $611 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $236 | $258 | $353 | |
| Operating activities | ||||
| Depreciation | $186 | $177 | $175 | |
| Business acquisitions & disposals | $2 | -$1192 | $9 | |
| Stock-based compensation | $33 | $31 | $28 | |
| Total cash flows from operations | $2077 | -$49 | $1189 | |
| Investing activities | ||||
| Capital expenditures | -$191 | -$104 | -$113 | |
| Investments | $355 | -$551 | -$1 | |
| Total cash flows from investing | -$88 | $166 | -$1847 | -$105 |
| Financing activities | ||||
| Dividends paid | -$128 | -$122 | -$122 | -$124 |
| Sale and purchase of stock | -$250 | |||
| Net borrowings | -$760 | $1131 | -$8 | |
| Total cash flows from financing | -$540 | -$859 | $1031 | -$353 |
| Effect of exchange rate | $9 | -$2 | -$8 | $6 |
| Change in cash and equivalents | -$2266 | $1382 | -$873 | $737 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $852 | $261 | -$933 | $611 |
| Operating activities | ||||
| Depreciation | $710 | $692 | $692 | $783 |
| Business acquisitions & disposals | -$1181 | -$10 | $901 | -$3 |
| Stock-based compensation | $121 | $96 | $81 | $89 |
| Total cash flows from operations | $3762 | $2839 | $3122 | $2429 |
| Investing activities | ||||
| Capital expenditures | -$499 | -$469 | -$356 | -$400 |
| Investments | -$169 | $25 | $22 | $25 |
| Total cash flows from investing | -$1849 | -$454 | $567 | -$378 |
| Financing activities | ||||
| Dividends paid | -$499 | -$525 | -$559 | -$573 |
| Sale and purchase of stock | -$750 | -$2000 | -$1000 | -$200 |
| Net borrowings | $356 | -$579 | -$885 | -$570 |
| Total cash flows from financing | -$847 | -$3051 | -$2463 | -$1317 |
| Effect of exchange rate | -$9 | -$8 | -$25 | $11 |
| Change in cash and equivalents | $1057 | -$674 | $1310 | $636 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -15.04 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |